Annual EBITDA
-$16.88 M
+$16.02 M+48.69%
December 31, 2023
Summary
- As of February 7, 2025, KRBP annual EBITDA is -$16.88 million, with the most recent change of +$16.02 million (+48.69%) on December 31, 2023.
- During the last 3 years, KRBP annual EBITDA has risen by +$2.12 million (+11.16%).
- KRBP annual EBITDA is now -444.09% below its all-time high of -$3.10 million, reached on December 31, 2018.
Performance
KRBP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$5.95 M
-$637.00 K-11.99%
September 30, 2024
Summary
- As of February 7, 2025, KRBP quarterly EBITDA is -$5.95 million, with the most recent change of -$637.00 thousand (-11.99%) on September 30, 2024.
- Over the past year, KRBP quarterly EBITDA has dropped by -$637.00 thousand (-11.99%).
- KRBP quarterly EBITDA is now -2300.32% below its all-time high of -$247.80 thousand, reached on June 30, 2019.
Performance
KRBP Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$19.28 M
-$2.75 M-16.67%
September 30, 2024
Summary
- As of February 7, 2025, KRBP TTM EBITDA is -$19.28 million, with the most recent change of -$2.75 million (-16.67%) on September 30, 2024.
- Over the past year, KRBP TTM EBITDA has dropped by -$2.75 million (-16.67%).
- KRBP TTM EBITDA is now -5175.51% below its all-time high of -$365.50 thousand, reached on March 31, 2019.
Performance
KRBP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
KRBP EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +48.7% | -12.0% | -16.7% |
| 3 y3 years | +11.2% | -1.2% | +30.8% |
| 5 y5 years | -444.1% | -1.2% | +30.8% |
KRBP EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +48.7% | -86.3% | +47.5% | -16.7% | +47.9% |
| 5 y | 5-year | -366.5% | +48.7% | -227.0% | +47.5% | -433.0% | +47.9% |
| alltime | all time | -444.1% | +48.7% | -2300.3% | +47.5% | -5175.5% | +47.9% |
Kiromic BioPharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.95 M(+12.0%) | -$19.28 M(+16.7%) |
| Jun 2024 | - | -$5.31 M(+17.5%) | -$16.53 M(-3.3%) |
| Mar 2024 | - | -$4.52 M(+29.0%) | -$17.10 M(+1.3%) |
| Dec 2023 | -$16.88 M(-48.7%) | -$3.50 M(+9.7%) | -$16.88 M(-14.4%) |
| Sep 2023 | - | -$3.19 M(-45.7%) | -$19.73 M(-29.2%) |
| Jun 2023 | - | -$5.88 M(+36.7%) | -$27.86 M(-7.2%) |
| Mar 2023 | - | -$4.30 M(-32.3%) | -$30.01 M(-8.8%) |
| Dec 2022 | -$32.89 M(+31.0%) | -$6.35 M(-43.9%) | -$32.89 M(-11.2%) |
| Sep 2022 | - | -$11.32 M(+40.9%) | -$37.03 M(+16.8%) |
| Jun 2022 | - | -$8.03 M(+11.9%) | -$31.70 M(+11.1%) |
| Mar 2022 | - | -$7.18 M(-31.6%) | -$28.53 M(+13.6%) |
| Dec 2021 | -$25.11 M | -$10.49 M(+75.1%) | -$25.11 M(+38.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$5.99 M(+23.2%) | -$18.09 M(+25.1%) |
| Jun 2021 | - | -$4.87 M(+29.6%) | -$14.47 M(-30.9%) |
| Mar 2021 | - | -$3.76 M(+7.9%) | -$20.93 M(+10.2%) |
| Dec 2020 | -$19.00 M(+425.1%) | -$3.48 M(+47.1%) | -$19.00 M(+7.6%) |
| Sep 2020 | - | -$2.37 M(-79.1%) | -$17.66 M(+9.3%) |
| Jun 2020 | - | -$11.33 M(+523.0%) | -$16.16 M(+218.6%) |
| Mar 2020 | - | -$1.82 M(-15.2%) | -$5.07 M(+40.2%) |
| Dec 2019 | -$3.62 M(+16.6%) | -$2.15 M(+149.9%) | -$3.62 M(+145.8%) |
| Sep 2019 | - | -$858.80 K(+246.6%) | -$1.47 M(+140.0%) |
| Jun 2019 | - | -$247.80 K(-32.2%) | -$613.30 K(+67.8%) |
| Mar 2019 | - | -$365.50 K | -$365.50 K |
| Dec 2018 | -$3.10 M | - | - |
FAQ
- What is Kiromic BioPharma annual EBITDA?
- What is the all time high annual EBITDA for Kiromic BioPharma?
- What is Kiromic BioPharma annual EBITDA year-on-year change?
- What is Kiromic BioPharma quarterly EBITDA?
- What is the all time high quarterly EBITDA for Kiromic BioPharma?
- What is Kiromic BioPharma quarterly EBITDA year-on-year change?
- What is Kiromic BioPharma TTM EBITDA?
- What is the all time high TTM EBITDA for Kiromic BioPharma?
- What is Kiromic BioPharma TTM EBITDA year-on-year change?
What is Kiromic BioPharma annual EBITDA?
The current annual EBITDA of KRBP is -$16.88 M
What is the all time high annual EBITDA for Kiromic BioPharma?
Kiromic BioPharma all-time high annual EBITDA is -$3.10 M
What is Kiromic BioPharma annual EBITDA year-on-year change?
Over the past year, KRBP annual EBITDA has changed by +$16.02 M (+48.69%)
What is Kiromic BioPharma quarterly EBITDA?
The current quarterly EBITDA of KRBP is -$5.95 M
What is the all time high quarterly EBITDA for Kiromic BioPharma?
Kiromic BioPharma all-time high quarterly EBITDA is -$247.80 K
What is Kiromic BioPharma quarterly EBITDA year-on-year change?
Over the past year, KRBP quarterly EBITDA has changed by -$637.00 K (-11.99%)
What is Kiromic BioPharma TTM EBITDA?
The current TTM EBITDA of KRBP is -$19.28 M
What is the all time high TTM EBITDA for Kiromic BioPharma?
Kiromic BioPharma all-time high TTM EBITDA is -$365.50 K
What is Kiromic BioPharma TTM EBITDA year-on-year change?
Over the past year, KRBP TTM EBITDA has changed by -$2.75 M (-16.67%)